Effects of sleep restriction on adiponectin levels in healthy men and women

Physiology and Behavior

Volumn 101, Issue 5, 2010, Pages 693-698

  Simpson, Norah S ^a,c   Banks, Siobhan ^b,c   Arroyo, Sylmarie ^c   Dinges, David F ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adiponectin; Ethnicity; Obesity; Race; Sex; Sleep restriction

Indexed keywords

ADIPONECTIN;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; MALE; NIGHT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE; SEX DIFFERENCE; SLEEP DEPRIVATION;

ADIPONECTIN; ADULT; AFRICAN AMERICANS; ANALYSIS OF VARIANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; POLYSOMNOGRAPHY; RADIOIMMUNOASSAY; SEX FACTORS; SLEEP DEPRIVATION;

EID: 78149280371     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.08.006     Document Type: Article

References (58)

1. Patel S.R., Hu F.B. Short sleep duration and weight gain: a systematic review. Obesity 2008, 16:643-653. (Silver Spring).
2. Wolff B., Volzke H., Schwahn C., Robinson D., Kessler C., John U. Relation of self-reported sleep duration with carotid intima-media thickness in a general population sample. Atherosclerosis 2008, 196:727-732.
3. King C.R., Knutson K.L., Rathouz P.J., Sidney S., Liu K., Lauderdale D.S. Short sleep duration and incident coronary artery calcification. J Am Med Assoc 2008, 300:2859-2866.
4. Eguchi K., Pickering T.G., Schwartz J.E., Hoshide S., Ishikawa J., Ishikawa S., et al. Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med 2008, 168:2225-2231.
5. Ikehara S., Iso H., Date C., Kikuchi S., Watanabe Y., Wada Y., et al. Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study. Sleep 2009, 32:259-301.
6. Ferrie J.E., Shipley M.J., Cappuccio F.P., Brunner E.J., Miller M.A., Kumari M., et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II Cohort. Sleep 2007, 30:1659-1666.
7. National Sleep Foundation 1997 Sleep in America Poll 1998, National Sleep Foundation, Washington, D.C.
8. National Sleep Foundation 2005 Sleep in America Poll 2006, National Sleep Foundation, Washington, D.C.
9. Tune G.S. Sleep and wakefulness in normal human adults. Br Med J 1968, 2:269-271.
10. Cappuccio F.P., Stranges S., Kandala N.B., Miller M.A., Taggart F.M., Kumari M., et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II study. Hypertension 2007, 50:693-700.
11. Miller M.A., Kandala N.B., Kivimaki M., Kumari M., Brunner E.J., Lowe G.D., et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep 2009, 37:857-864.
12. Meisinger C., Heier M., Lowel H., Schneider A., Doring A. Sleep duration and sleep complaints and risk of myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study. Sleep 2007, 30:1121-1127.
13. Goldstein B.J., Scalia R.G., Ma X.L. Protective vascular and myocardial effects of adiponectin. Nature clinical practice. Cardiovasc Med 2009, 6:27-35.
14. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001, 86:1930-1935.
15. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001, 7:941-946.
16. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999, 257:79-83.
17. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L.G., Murphy L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003, 149:331-335.
18. Li S., Shin H.J., Ding E.L., van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. J Am Med Assoc 2009, 302:179-188.
19. Maahs D.M., Ogden L.G., Kinney G.L., Wadwa P., Snell-Bergeon J.K., Dabelea D., et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005, 111:747-753.
20. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. J Am Med Assoc 2004, 291:1730-1734.
21. Schnabel R., Messow C.M., Lubos E., Espinola-Klein C., Rupprecht H.J., Bickel C., et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008, 29:649-657.
22. Schulze M.B., Shai I., Rimm E.B., Li T., Rifai N., Hu F.B. Adiponectin and future coronary heart events among men with Type 2 diabetes. Diabetes 2005, 54:534-539.
23. Lawlor D.A., Smith G.D., Ebrahim S., Thompson C., Sattar N. Plasma adiponectin levels are associated with insulin resistance but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005, 90:5677-5683.
24. Hitze B., Bosy-Westphal A., Bielfeldt F., Settler U., Plachta-Danielzik S., Pfeuffer M., et al. Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study. Eur J Clin Nutr 2008, 63:739-746.
25. Taheri S., Lin L., Austin D., Young T., Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004, 1:210-217.
26. Williams C.J., Hu F.B., Patel S.R., Mantzoros C.S. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with Type 2 diabetes. Diab Care 2007, 30:1233-1240.
27. Shea S.A., Hilton M.F., Orlova C., Ayers R.T., Mantzoros C.S. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab 2005, 90:2537-2544.
28. Mullington J.M., Haack M., Toth M., Serrador J.M., Meier-Ewert H.K. Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis 2009, 51:294-302.
29. Meier-Ewert H.K., Ridker P.M., Rifai N., Regan M.M., Price N.J., Dinges D.F., et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004, 43:678-683.
30. Spiegel K., Leproult R., L'Hermite-Baleriaux M., Copinschi G., Penev P.D., Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004, 89:5762-5771.
31. Spiegel K., Tasali E., Penev P., Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
32. Lloyd-Jones D., Adams R., Carnethon M., De Simone G., Ferguson T.B., Flegal K., et al. Heart disease and stroke statistics-2009 update: a reports from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:480-486.
33. Rechtschaffen A., Kales A.E. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages in Human Subjects 1968, U.S. Government Printing Office, Washington, D.C. A. Rechtschaffen, A. Kales (Eds.).
34. Suarez E.C. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: evidence for a gender disparity. Brain Behav Immun 2008, 22:960-968.
35. Simpson N.S., Banks S., Dinges D.F. Sleep restriction is associated with increased morning plasma leptin concentrations, especially among women. Biological Research For Nursing 2010, 12:47-53.
36. Hale L., Do D.P. Racial differences in self-reports of sleep duration in a population-based study. Sleep 2007, 3:1096-1103.
37. Nunes J., Jean-Louis G., Zizi F., Casimir G.J., von Gizycki H, Brown CD, et al. Sleep duration among black and white Americans: results of the National Health Interview Survey. J Natl Med Assoc 2008, 100:317-322.
38. Cooper D.C., Ziegler M.G., Nelesen R.A., Dimsdale J.E. Racial differences in the impact of social support on nocturnal blood pressure. Psychosom Med 2009, 71:524-531.
39. Spruill T.M., Gerin W., Ogedegbe G., Burg M., Schwartz J.E., Pickering T.G. Socioeconomic and psychosocial factors mediate race differences in nocturnal blood pressure dipping. Am J Hypertens 2009, 22:637-642.
40. Troxel W.M., Buysse D.J., Hall M., Kamarck T.W., Strollo P.J., Owens J.F., et al. Social interaction, social contacts, and blood pressure dipping in African-Americans and whites. J Hypertens 2010, 28:265-271.
41. Fain J.N., Madan A.K., Hiler M.L., Cheema P., Bahouth S.W. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004, 145:2273-2282.
42. Demerath E.W., Sun S.S., Rogers N., Lee M., Reed D., Choh A.C., et al. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity 2007, 15:2984-2993. (Silver Spring).
43. Rahman M., Temple J.R., Brietkopf C.R., Berenson A.B. Racial differences in body fat distribution among reproductive-aged women. Metab, Clin Exp 2009, 58:1329-1337.
44. Carroll J.F., Chiapa A.L., Rodriquez M., Phelps D.R., Cardarelli K.M., Vishwanatha J.K., et al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity 2008, 16:600-607. (Silver Spring).
45. Conway J.M., Yanovski S.Z., Avila N.A., Hubbard V.S. Visceral adipose tissue differences in black and white women. Am J Clin Nutr 1995, 61:765-771.
46. Kanaley J.A., Giannopoulou I., Tillapaugh-Fay G., Nappi J.S., Ploutz-Snyder L.L. Racial differences in subcutaneous and visceral fat distribution in postmenopausal black and white women. Metabolism 2003, 52:186-191.
47. Lovejoy J.C., de la Bretonne J.A., Klemperer M., Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996, 45:1119-1124.
48. Wee C.C., Mukamal K.J., Huang A., Davis R.B., McCarthy E.P., Mittleman M.A. Obesity and C-reactive protein levels among white, black, and Hispanic US adults. Obesity 2008, 16:875-880. (Silver Spring).
49. Haack M., Sanchez E., Mullington J.M. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep 2007, 30:1145-1152.
50. Banks S., Jones C.W., Simpson N.S., Dinges D.F. Sustained sleep restriction in healthy adults with ad libitum access to food results in weight gain without increased appetite or food cravings [Abstract]. Sleep 2009, 32:A128.
51. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics - 2008 update. Circulation 2008, 117:e25-e146.
52. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
53. Nedeltcheva A.V., Kilkus J.M., Imperial J., Kasza K., Schoeller D.A., Penev P.D. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr 2009, 89:1-8.
54. Schmid S.M., Hallschmid M., Jauch-Chara K., Wilms B., Benedict C., Lehnert H., et al. Short-term sleep loss decreases physical activity under free-living conditions but does not increase food intake under time-deprived laboratory conditions in healthy men. Am J Clin Nutr 2009, 90:1476-1482.
55. Esposito K., Nappo F., Giugliano F., De Palo C., Ciotola M., Barbieri M., et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 2003, 78:1135-1140.
56. Lely A.T., Krikken J.A., Bakker S.J., Boomsma F., Dullaart R.P., Wolffenbuttel B.H., et al. Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men. J Clin Endocrinol Metab 2007, 92:1821-1826.
57. Nakandakare E.R., Charf A., Santos F.C., Nunes V.S., Ortega K., Lottenberg A.M., et al. Dietary salt restriction increases plasma lipoprotein and inflammatory marker concentrations in hypertensive patients. Atherosclerosis 2008, 200:410-416.
58. Van Dongen H.P.A., Baynard M.D., Maislin G., Dinges D.F. Systematic inter-individual differences in neurobehavioral impairment from sleep loss: evidence of trait-like differential vulnerability. Sleep 2004, 27:423-433.